Bioinnovation Enterprise: An engine driving breakthrough therapies.
Publication/Presentation Date
1-1-2016
Abstract
Biological advances have radically expanded our insights into the underpinnings of health and disease. New knowledge has formed the substrate for translation-expedited in turn by the biotechnology and pharmaceutical industry into novel therapeutic solutions impacting the management of patients and populations. Indeed, this Bioinnovation Enterprise has become the dominant growth sector in drug development and the engine driving the translation of breakthrough therapies worldwide. This annual Therapeutic Innovations issue highlights recent exceptional advances by the Bioinnovation Enterprise in translating molecular insights in pathobiology into transformative therapies.
Volume
99
Issue
1
First Page
8
Last Page
13
ISSN
1532-6535
Published In/Presented At
Waldman, S. A., & Terzic, A. (2016). Bioinnovation Enterprise: An engine driving breakthrough therapies. Clinical pharmacology and therapeutics, 99(1), 8–13. https://doi.org/10.1002/cpt.272
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
26785918
Department(s)
Administration and Leadership
Document Type
Article